Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

New Approaches to Human Immunology

Mark Davis, PhD

Blood (2017) 130 (Supplement 1): SCI-47.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-47.SCI-47

Published: 2017

Journal Articles

Post-Transplantation Cyclophosphamide Induces Alloreactive T-Cell Functional Impairment and Depends on Foxp3 + Regulatory T Cells Not Selective Elimination or Intrathymic Clonal Deletion of Alloreactive T Cells

Lucas P. Wachsmuth, Michael T. Patterson, Michael A. Eckhaus, DVM, Ronald E. Gress, MD, Christopher G. Kanakry, MD

Blood (2017) 130 (Supplement 1): 4433.

https://doi.org/10.1182/blood.V130.Suppl_1.4433.4433

Published: 2017

Journal Articles

Clonal Deletion Plays a Major Role to Achieve Immune Tolerance after Reduced Intensity Unrelated Donor Cord Blood Transplantation (UCBT)

Paul Szabolcs, MD, Xiaohua Chen, MD PhD, Mark Vander Lugt, MD, Memphis J Hill, BS

Blood (2016) 128 (22): 4584.

https://doi.org/10.1182/blood.V128.22.4584.4584

Published: 2016

Journal Articles

Prenatal Allospecific Tolerance Is Characterized By Early T reg Expansion and a Surprisingly Slow Pace for T eff Clonal Deletion

Beverly SI Strong, PhD, Amanda E Lee, MD, Tess J Newkold, Lucas E Turner, Aimen F Shaaban, MD

Blood (2015) 126 (23): 3070.

https://doi.org/10.1182/blood.V126.23.3070.3070

Published: 2015

Journal Articles

Subclonal IKZF1 Deletions Indicate a Multiclonal Evolution In BCR-ABL1-Positive B-Cell Precursor ALL

Verena Boehm, PhD, Annett Lebenatus, Marius Bartels, Inga Nagel, PhD, Heiko Trautmann, PhD, Nicola Gökbuget, MD, Dieter Hoelzer, MD, Heike Pfeifer, MD, Reiner Siebert, MD, Michael Kneba, MD, Oliver Ottmann, MD, Monika Brüggemann, MD

Blood (2013) 122 (21): 1327.

https://doi.org/10.1182/blood.V122.21.1327.1327

Published: 2013

Journal Articles

Clonal Evolution In Patients With Chronic Lymphocytic Leukemia (CLL) Developing Resistance To BTK Inhibition

Jan A. Burger, MD, PhD, Dan Landau, M.D., Julia Hoellenriegel, Carrie Sougnez, Matthias Schlesner, Naveed Ishaque, Benedikt Brors, Michael J. Keating, MD, William G. Wierda, MD, Kristian Cibulskis, Hagop M. Kantarjian, MD, Susan M. O'Brien, MD, Donna S. Neuberg, ScD, Thorsten Zenz, MD, Gad Getz, Catherine J Wu, MD

Blood (2013) 122 (21): 866.

https://doi.org/10.1182/blood.V122.21.866.866

Published: 2013

Journal Articles

Very High Risk CLL Characterized by a “Double Hit” Clone with Both 11q22 and 17p13 Deletion.

Patricia T. Greipp, D.O., Stephanie A. Smoley, David S. Viswanatha, MD, Lori S. Frederick, BS, Ruchi G. Sharma, Kari G. Rabe, MS, Susan L Slager, PhD, Daniel L. Van Dyke, Ph.D., Neil E. Kay, MD, Tait D. Shanafelt, MD, Clive S. Zent, MD

Blood (2012) 120 (21): 2486.

https://doi.org/10.1182/blood.V120.21.2486.2486

Published: 2012

Journal Articles

Deciphering of CD4 + T Cell Subsets Involved in Maintenance and Break of Immune Tolerance in a Humanized Mouse Model That Is Immune Tolerant to Human FVII

Christine Lenk, Markus Pasztorek, Markus Weiller, PhD, Rafi Uddin Ahmad, PhD, Hans Peter Schwarz, MD, Friedrich Scheiflinger, PhD, Birgit M Reipert, PhD, Maurus de la Rosa, PhD

Blood (2011) 118 (21): 2188.

https://doi.org/10.1182/blood.V118.21.2188.2188

Published: 2011

Journal Articles

Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion

Sara Morlacchi, Cristiana Soldani, Antonella Viola, Adelaida Sarukhan

Blood (2011) 118 (4): 984–991.

https://doi.org/10.1182/blood-2011-02-336115

Published: 2011

Includes: Supplemental data

Journal Articles

Ex vivo–expanded DCs induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin grafts

Tomoyoshi Yamano, Sho Watanabe, Hiroyuki Hasegawa, Toshihiro Suzuki, Ryo Abe, Hideaki Tahara, Takeshi Nitta, Naozumi Ishimaru, Jonathan Sprent, Hidehiro Kishimoto

Blood (2011) 117 (9): 2640–2648.

https://doi.org/10.1182/blood-2010-07-293860

Published: 2011

Includes: Supplemental data

Journal Articles

Functional PRAME Specific T Cells Can Be Cultured From CD8+ Cells From Healthy Donors but Not From Patients at First CR: Implications for Immunotherapeutic Strategies in AML.

Willemijn van den Ancker, Theresia M Westers, PhD, Hetty J Bontkes, PhD, Dewi Wulandari, Erik Hooijberg, PhD, Anita GM Stam, Saskia JAM Santegoets, PhD, Gert J Ossenkoppele, MD, PhD, Tanja D de Gruijl, PhD, Arjan A van de Loosdrecht, MD, PhD

Blood (2009) 114 (22): 4139.

https://doi.org/10.1182/blood.V114.22.4139.4139

Published: 2009

Journal Articles

Deletion 13q in B-CLL: Interphase FISH Reveals More 13q- Than Does CpG Stimulation.

Daniel L. Van Dyke, PhD, G.W. Dewald, PhD, T.G. Call, MD, D.F. Jelinek, PhD, C.S. Zent, MD, T.D. Shanafelt, MD, S.A. Smoley, K.J. Stockero, N.E. Kay

Blood (2007) 110 (11): 2070.

https://doi.org/10.1182/blood.V110.11.2070.2070

Published: 2007

Journal Articles

Double Negative T Cells Influence TCR VB Variablity to Induce Allotolerance.

Zachariah A. McIver, DO, Marcin Wlodarski, MD, Jennifer Powers, BS, Christine O’Keefe, PhD, Tao Jin, MS, Ronald Sobecks, MD, Brian J. Bolwell, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2006) 108 (11): 759.

https://doi.org/10.1182/blood.V108.11.759.759

Published: 2006

Journal Articles

In Vivo T-Lymphocyte Tolerance in the Absence of Thymic Clonal Deletion Mediated by Hematopoietic Cells

Joost P.M. van Meerwijk, H. Robson MacDonald

Blood (1999) 93 (11): 3856–3862.

https://doi.org/10.1182/blood.V93.11.3856

Published: 1999

NARROW

New Approaches to Human Immunology

Post-Transplantation Cyclophosphamide Induces Alloreactive T-Cell Functional Impairment and Depends on Foxp3 + Regulatory T Cells Not Selective Elimination or Intrathymic Clonal Deletion of Alloreactive T Cells

Clonal Deletion Plays a Major Role to Achieve Immune Tolerance after Reduced Intensity Unrelated Donor Cord Blood Transplantation (UCBT)

Prenatal Allospecific Tolerance Is Characterized By Early T reg Expansion and a Surprisingly Slow Pace for T eff Clonal Deletion

Subclonal IKZF1 Deletions Indicate a Multiclonal Evolution In BCR-ABL1-Positive B-Cell Precursor ALL

Clonal Evolution In Patients With Chronic Lymphocytic Leukemia (CLL) Developing Resistance To BTK Inhibition

Very High Risk CLL Characterized by a “Double Hit” Clone with Both 11q22 and 17p13 Deletion.

Deciphering of CD4 + T Cell Subsets Involved in Maintenance and Break of Immune Tolerance in a Humanized Mouse Model That Is Immune Tolerant to Human FVII

Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion

Ex vivo–expanded DCs induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin grafts

Functional PRAME Specific T Cells Can Be Cultured From CD8+ Cells From Healthy Donors but Not From Patients at First CR: Implications for Immunotherapeutic Strategies in AML.

Deletion 13q in B-CLL: Interphase FISH Reveals More 13q- Than Does CpG Stimulation.

Double Negative T Cells Influence TCR VB Variablity to Induce Allotolerance.

In Vivo T-Lymphocyte Tolerance in the Absence of Thymic Clonal Deletion Mediated by Hematopoietic Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only